Paper1998970
Blocked and non-blocked ricin immunotoxins against the CD4 antigen exhibit higher cytotoxic potency than a ricin A chain immunotoxin potentiated with ricin B chain or with a ricin B chain immunotoxin.
Wawrzynczak EJ and 6 others. Cancer Immunol Immunother, 1991. Cited by 29 papers, by iCite.
Cite this record
ConductScience Library. Blocked and non-blocked ricin immunotoxins against the CD4 antigen exhibit higher cytotoxic potency than a ricin A chain immunotoxin potentiated with ricin B chain or with a ricin B chain immunotoxin. Papers, record 1998970. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/1998970
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Blocked and non-blocked ricin immunotoxins against the CD4 antigen exhibit higher cytotoxic potency than a ricin A chain immunotoxin potentiated with ricin B chain or with a ricin B chain immunotoxin.
- PubMed
Topics19
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| CD4 Antigens | Major topic |
| Immunotoxins | Major topic |
| Ricin | Major topic |
| Animals | |
| Antibodies, Monoclonal | |
| B-Lymphocytes | |
| Binding Sites | |
| Binding, Competitive | |
| Cell Survival | |
| Cells, Cultured | |
| Galactose | |
| Goats | |
| Humans | |
| Lactose | |
| Mice | |
| Neoplasms | |
| Peptides | |
| T-Lymphocytes | |
| Tumor Cells, Cultured |
Source PubMed
References23
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 3495593 | Whole ricin and recombinant ricin A chain idiotype-specific immunotoxins for therapy of the guinea pig L2C B cell leukemia. | J Immunol | 1987 | https://conductscience.org/library/papers/3495593 | PubMed |
| 2 | 2957434 | Inhibition of the helper function of murine T cells with Fab'-anti-L3T4 ricin A chain immunotoxin. | J Immunol | 1987 | https://conductscience.org/library/papers/2957434 | PubMed |
| 3 | 3495199 | Purification of immunotoxins containing ricin A-chain and abrin A-chain using blue sepharose CL-6B. | Anal Biochem | 1987 | https://conductscience.org/library/papers/3495199 | PubMed |
| 4 | 3261884 | Human T lymphocyte differentiation antigens as target for immunotoxins or complement-mediated cytotoxicity. | Scand J Immunol | 1988 | https://conductscience.org/library/papers/3261884 | PubMed |
| 5 | 3064097 | Antibody toxin conjugates: a perspective. | Prog Allergy | 1988 | https://conductscience.org/library/papers/3064097 | PubMed |
| 6 | 3317828 | Redesigning nature's poisons to create anti-tumor reagents. | Science | 1987 | https://conductscience.org/library/papers/3317828 | PubMed |
| 7 | 3957927 | Purification of ricin A1, A2, and B chains and characterization of their toxicity. | J Biol Chem | 1986 | https://conductscience.org/library/papers/3957927 | PubMed |
| 8 | 2430333 | Epitopes of the CD4 antigen and HIV infection. | Science | 1986 | https://conductscience.org/library/papers/2430333 | PubMed |
| 9 | 3876881 | Kinetics of protein synthesis inactivation in human T-lymphocytes by selective monoclonal antibody-ricin conjugates. | Cancer Res | 1985 | https://conductscience.org/library/papers/3876881 | PubMed |
| 10 | 4338881 | The interaction of Ricinus communis agglutinin with normal and tumor cell surfaces. | Biochim Biophys Acta | 1972 | https://conductscience.org/library/papers/4338881 | PubMed |
| 11 | 6120167 | Kinetics of protein synthesis inactivation by ricin-anti-Thy 1.1 monoclonal antibody hybrids. Role of the ricin B subunit demonstrated by reconstitution. | J Biol Chem | 1982 | https://conductscience.org/library/papers/6120167 | PubMed |
| 12 | 7471212 | Studies on the galactose-binding site of ricin and the hybrid toxin Man6P-ricin. | Cell | 1981 | https://conductscience.org/library/papers/7471212 | PubMed |
| 13 | 6544125 | Delivery of ricin and abrin A-chains to human carcinoma cells in culture following covalent linkage to monoclonal antibody LICR-LOND-Fib 75. | Cancer Drug Deliv | 1984 | https://conductscience.org/library/papers/6544125 | PubMed |
| 14 | 7042536 | The preparation and cytotoxic properties of antibody-toxin conjugates. | Immunol Rev | 1982 | https://conductscience.org/library/papers/7042536 | PubMed |
| 15 | 6578512 | Synergy of ricin A chain-containing immunotoxins and ricin B chain-containing immunotoxins in in vitro killing of neoplastic human B cells. | Proc Natl Acad Sci U S A | 1983 | https://conductscience.org/library/papers/6578512 | PubMed |
| 16 | 2445469 | Studies on the mechanism of action of abrin-9.2.27 immunotoxin in human melanoma cell lines. | Cancer Res | 1987 | https://conductscience.org/library/papers/2445469 | PubMed |
| 17 | 6736871 | Cytotoxicity of a cell-reactive immunotoxin containing ricin A chain is potentiated by an anti-immunotoxin containing ricin B chain. | J Exp Med | 1984 | https://conductscience.org/library/papers/6736871 | PubMed |
| 18 | 3900635 | Preparation of antibody-toxin conjugates. | Methods Enzymol | 1985 | https://conductscience.org/library/papers/3900635 | PubMed |
| 19 | 2841982 | Ricin B chain-containing immunotoxins prepared with heat-denatured B chain lacking galactose-binding ability potentiate the cytotoxicity of a cell-reactive ricin A chain immunotoxin. | Biochim Biophys Acta | 1988 | https://conductscience.org/library/papers/2841982 | PubMed |
| 20 | 6653781 | Ricin B chain converts a non-cytotoxic antibody-ricin A chain conjugate into a potent and specific cytotoxic agent. | FEBS Lett | 1983 | https://conductscience.org/library/papers/6653781 | PubMed |
Cited by11
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 29 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 31359089 | Ricin and Ricinus communis in pharmacology and toxicology-from ancient use and "Papyrus Ebers" to modern perspectives and "poisonous plant of the year 2018". | Naunyn Schmiedebergs Arch Pharmacol | 2019 | https://conductscience.org/library/papers/31359089 | PubMed |
| 29076988 | The Use of Plant-Derived Ribosome Inactivating Proteins in Immunotoxin Development: Past, Present and Future Generations. | Toxins (Basel) | 2017 | https://conductscience.org/library/papers/29076988 | PubMed |
| 26349746 | Potential therapeutic applications of plant toxin-ricin in cancer: challenges and advances. | Tumour Biol | 2015 | https://conductscience.org/library/papers/26349746 | PubMed |
| 25341935 | Immunotoxins constructed with ribosome-inactivating proteins and their enhancers: a lethal cocktail with tumor specific efficacy. | Curr Pharm Des | 2014 | https://conductscience.org/library/papers/25341935 | PubMed |
| 22191802 | Synthesis of a covalent epirubicin-(C(3)-amide)-anti-HER2/neu immunochemotherapeutic utilizing a UV-photoactivated anthracycline intermediate. | Cancer Biother Radiopharm | 2012 | https://conductscience.org/library/papers/22191802 | PubMed |
| 10569193 | Comparative studies on kinetics of inhibition of protein synthesis in intact cells by ricin and a conjugate of ricin B-chain with momordin. | Mol Cell Biochem | 1999 | https://conductscience.org/library/papers/10569193 | PubMed |
| 9685864 | Effect of gelonin immunoconjugate with monoclonal antibody MSN-1 to endometrial adenocarcinoma on antigen-producing tumor cells in vivo. | Jpn J Cancer Res | 1998 | https://conductscience.org/library/papers/9685864 | PubMed |
| 1911210 | Systemic immunotoxin therapy of cancer: advances and prospects. | Br J Cancer | 1991 | https://conductscience.org/library/papers/1911210 | PubMed |
| 1394342 | Antitumour activity of a sterically blocked ricin immunotoxin on a human colorectal adenocarcinoma grafted subcutaneously in nude mice. | Cancer Immunol Immunother | 1992 | https://conductscience.org/library/papers/1394342 | PubMed |
| 1394340 | Blocked ricin-conjugated T cell immunotoxins: effect of anti-CD6-blocked ricin on normal T cell function. | Cancer Immunol Immunother | 1992 | https://conductscience.org/library/papers/1394340 | PubMed |
| 1287032 | Targeted kill: from umbrellas to monoclonal antibodies. | J Clin Immunol | 1992 | https://conductscience.org/library/papers/1287032 | PubMed |
Genes1
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes |
|---|---|---|---|
| CD4 | 920 | PubTator's text mining | https://conductscience.org/library/genes/920 |
Source NCBI Gene
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/1998970
GET https://conductscience.org/api/papers/v1/1998970/references?page=2